Featured Research

from universities, journals, and other organizations

Prompt Diagnosis Of Ear Infections Can Improve Outcome For Organ Transplant Recipients

Date:
October 5, 2009
Source:
American Academy of Otolaryngology -- Head and Neck Surgery
Summary:
Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

In a paper presented at the 2009 American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers reviewed the medical records of 3,278 patients who received solid organ transplantation between February 1995 and December 2007 at a medical center in Seoul, South Korea.

The study showed that 65 (2 %) of the organ transplant patients had chronic otitis media. Thirty-one cases were from liver transplantation, 28 cases from renal transplantation, and six cases from heart transplantation. Bacterial growth was present in 17 out of 40 isolates. Of those 65 patients, nine underwent surgery, 26 improved with antibiotic treatment, and 30 patients were observed without definite treatment during the pre-transplantation period. After transplantation, aggravation of chronic otitis media was lower in patients receiving surgery than in patients receiving antibiotic therapy or observation alone.

According to the authors, immunosuppressed patients who have undergone organ transplantation can have a clinically hidden otitis media infection which can result in one of the most common life-threatening complications, transplantation failure. So effective treatment of otitis media in these patients appears to be a significant determinant in the success of organ transplantation.


Story Source:

The above story is based on materials provided by American Academy of Otolaryngology -- Head and Neck Surgery. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Otolaryngology -- Head and Neck Surgery. "Prompt Diagnosis Of Ear Infections Can Improve Outcome For Organ Transplant Recipients." ScienceDaily. ScienceDaily, 5 October 2009. <www.sciencedaily.com/releases/2009/10/091004140945.htm>.
American Academy of Otolaryngology -- Head and Neck Surgery. (2009, October 5). Prompt Diagnosis Of Ear Infections Can Improve Outcome For Organ Transplant Recipients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/10/091004140945.htm
American Academy of Otolaryngology -- Head and Neck Surgery. "Prompt Diagnosis Of Ear Infections Can Improve Outcome For Organ Transplant Recipients." ScienceDaily. www.sciencedaily.com/releases/2009/10/091004140945.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins